Novo Integrated Sciences (NASDAQ:NVOS) Trading 2.6% Higher

Novo Integrated Sciences, Inc. (NASDAQ:NVOSGet Free Report)’s share price shot up 2.6% during trading on Wednesday . The stock traded as high as $0.32 and last traded at $0.30. 107,216 shares were traded during mid-day trading, a decline of 96% from the average session volume of 3,061,625 shares. The stock had previously closed at $0.29.

Novo Integrated Sciences Trading Up 2.6 %

The company has a quick ratio of 0.22, a current ratio of 0.27 and a debt-to-equity ratio of 0.01. The firm has a 50 day moving average of $0.55 and a 200 day moving average of $0.60.

Novo Integrated Sciences (NASDAQ:NVOSGet Free Report) last posted its quarterly earnings data on Friday, July 19th. The company reported ($0.74) EPS for the quarter. Novo Integrated Sciences had a negative net margin of 179.95% and a negative return on equity of 122.84%. The firm had revenue of $3.15 million during the quarter.

Novo Integrated Sciences Company Profile

(Get Free Report)

Novo Integrated Sciences, Inc, together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services.

See Also

Receive News & Ratings for Novo Integrated Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novo Integrated Sciences and related companies with MarketBeat.com's FREE daily email newsletter.